15-48610768-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000138.5(FBN1):c.306C>A(p.Cys102Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. C102C) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000138.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.306C>A | p.Cys102Ter | stop_gained | 4/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.306C>A | p.Cys102Ter | stop_gained | 3/65 | NP_001393645.1 | ||
FBN1 | NM_001406717.1 | c.306C>A | p.Cys102Ter | stop_gained | 4/9 | NP_001393646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.306C>A | p.Cys102Ter | stop_gained | 4/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 | |
FBN1 | ENST00000559133.6 | c.306C>A | p.Cys102Ter | stop_gained, NMD_transcript_variant | 4/67 | 1 | ENSP00000453958 | |||
FBN1 | ENST00000674301.2 | c.306C>A | p.Cys102Ter | stop_gained, NMD_transcript_variant | 4/68 | ENSP00000501333 | ||||
FBN1 | ENST00000537463.6 | c.306C>A | p.Cys102Ter | stop_gained, NMD_transcript_variant | 4/31 | 5 | ENSP00000440294 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 30, 2016 | The novel C102X likely pathogenic variant in the FBN1 gene has not been published as a pathogenic or benign variant to our knowledge. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The C102X variant is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Furthermore, many other nonsense variants in the FBN1 gene have been reported in HGMD in association with Marfan syndrome (Stenson et al., 2014). In summary, C102X in the FBN1 gene is expected to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at